Replies to post #39462 on RespireRx Pharmaceuticals Inc (RSPI)

[davidal66]

Any guesses on the nature of a reverse split? Would the goal be to raise the sp above 1 buck? 50-1 or so?? At this point it's kind of play money(considering I lost so much many moons ago).

I think the technology is beyond compelling for RD(and probably ADHD), but artifact gremlins would keep me on the sidelines here. Keep in mind that phase IIb and phase III testing require greater duration toxicology than phase I and IIa testing. Still, it's possible that new artifact issues will not arise this time.

The really interesting scenario down the road is the following...many years ahead.... that RSPI garners approval for RD and markets it. By this time, the safety issues and toxicology issues will be known beyond any doubt. At that time, Cortex could pursue adult ADHD which would be a huge market(as is RD).

So this will be a very interesting story down the road. I have a thousand bucks left from my old Cortex days, selling the bulk for a whopping price of 6 cents =). I will definitely keep the thousand bucks in RSPI for a lotto play.

So, this is a very long term play.... RS, RD trials(and more important longer term toxicology down the road) and the 'weed' drug as well. But the new Cortex company is a very interesting story indeed.